Phenazine derivatives as antimicrobial agents
US-2016355487-A1 · Dec 8, 2016 · US
US10526293B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10526293-B2 |
| Application number | US-201515509080-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 4, 2015 |
| Priority date | Sep 8, 2014 |
| Publication date | Jan 7, 2020 |
| Grant date | Jan 7, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
(in formula (1), C* are each carbon atoms adjacent to each other for forming a fullerene skeleton, A is a linking group having 1-4 carbon atoms for forming a ring structure with two C*, in which a portion thereof may be a substituted or condensed group).
Opening claim text (preview).
What is claimed is: 1. A method for producing a fullerene derivative having a partial structure represented by Formula (1), by reacting two carbon atoms adjacent to each other for forming a fullerene skeleton with a halogenated compound represented by Formula (2) in a mixed solvent of an aromatic solvent and an aprotic polar solvent having a C═O or S═O bond in the presence of at least one metal selected from the group consisting of manganese, iron and zinc: (in Formula (1), C* each represent carbon atoms adjacent to each other for forming a fullerene skeleton, A represents a linking group with 1 to 4 carbon atoms for forming a ring structure or a functional group in which the linking group is partially substituted or condensed) (in Formula (2), A represents a linking group with 1 to 4 carbon atoms or a functional group in which the linking group is partially substituted or condensed, and each X independently represents a halogen atom). 2. The method for producing a fullerene derivative according to claim 1 , wherein the linking group with 1 to 4 carbon atoms for A in Formulas (1) and (2) is partially substituted by an aromatic group, a heteroaromatic group, an alkoxycarbonyl group or an alkylidene group. 3. The method for producing a fullerene derivative according to claim 1 , wherein the linking group with 1 to 4 carbon atoms for A in Formulas (1) and (2) partially forms a condensed-ring structure or a polycyclic structure comprising an aromatic ring or a heteroaromatic ring with an aromatic ring or a heteroaromatic ring. 4. The method for producing a fullerene derivative according to claim 1 , wherein the aprotic polar solvent is one or more of the group consisting of dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). 5. The method for producing a fullerene derivative according to claim 1 , wherein the aromatic solvent is o-dichlorobenzene. 6. The method for producing a fullerene derivative according to claim 1 , wherein the halogen atom (X) is Br. 7. The method for producing a fullerene derivative according to claim 1 , wherein the metal is Mn, and the aprotic polar solvent is DMF. 8. The method for producing a fullerene derivative according to claim 1 , wherein the metal is Fe, and the aprotic polar solvent is DMSO. 9. The method for producing a fullerene derivative according to claim 1 , wherein the metal is Mn or Zn, and the aprotic polar solvent is DMSO.
with a bridged ring system · CPC title
of hydrocarbons and halogenated hydrocarbons · CPC title
having seven-membered rings, e.g. azelastine, pentylenetetrazole · CPC title
starting from organic compounds containing only halogen atoms as hetero-atoms · CPC title
not condensed and containing further heterocyclic rings, e.g. timolol · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.